CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment
Co-PARENT
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this research study is to collect information to better understand caregiver responses to COVID-19 stress and to help caregivers cope with these stressors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started May 2020
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 12, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2020
CompletedDecember 1, 2020
November 1, 2020
6 months
June 12, 2020
November 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Measure of Anxiety as assessed by the OASIS
The Overall Anxiety Severity and Impairment Scale (OASIS) is a 5 self-reported questionnaire evaluating the severity and functional impairment due to anxiety. The total score ranges from 0 (no anxiety) to 20 (severe anxiety).
week 6 and week 12
Measure of Depression as assessed by the ODSIS
Overall Depression Severity and Impairment Scale (ODSIS) is a 5-item measure assessing the frequency and intensity of depressive symptoms. The total score ranges from 0-20 with the higher score indicating increased depression.
week 6 and week 12
Measure of PTSD as assessed by the PCL-5
PTSD Checklist (PCL-5) is a 20-item measure of PTSD symptoms in adults. Total score ranges from 0 to 80 with the higher score indicating higher PTSD symptoms.
week 6 and week 12
Secondary Outcomes (4)
Measure of Parenting Overprotection/Overcontrol as assessed by the S-EMBU
week 6 and week 12
Measure of Parenting Rejection as assessed by the S-EMBU
week 6 and week 12
Measure of Parenting Emotional Warmth as assessed by the S-EMBU
week 6 and week 12
Measure of Parent Accommodation for Child Anxiety as assessed by the FASA
week 6 and week 12
Study Arms (2)
Immediate Condition
EXPERIMENTALParticipants in the Immediate Condition group will receive a total of 4 sessions of Unified Protocol for COVID-19 Parenting Stress (UP-COVID) intervention
Delayed Condition
ACTIVE COMPARATORParticipants in the Delayed Condition group will receive the Self Help Guide (SHG) by the National Child Traumatic Stress Network (NCTSN). They will then receive the UP-COVID intervention following their week 6 assessment
Interventions
UP-COVID is a group therapy session with each session lasting approximately 60-90 minutes. The sessions will focus on cognitive and behavioral strategies for managing their own distress, anxiety and sadness related to COVID-19, as well as, strategies related to parenting in the midst of the crisis.
Eligibility Criteria
You may qualify if:
- consent to participate via RedCap
- indicate a mild or greater elevation on screening measures of anxiety, depression and/or traumatic stress
- have a child between 6 and 13 years
- speak/read English or Spanish fluently
You may not qualify if:
- reported severe mental illness (e.g., bipolar disorder, schizophrenia, an intellectual disability, psychosis, alcohol use disorder, substance use disorder) or hospitalization for mental health concerns or suicide attempt.
- reported prior arrest for child endangerment, child abuse or child neglect, or prior investigation by the Florida Department of Children and Families (DCF)
- may be excluded if the severity of current mental illness is such that outpatient, weekly group treatment would be considered inappropriate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33146, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill Ehrenreich-May, Ph.D.
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 12, 2020
First Posted
June 16, 2020
Study Start
May 15, 2020
Primary Completion
November 17, 2020
Study Completion
November 17, 2020
Last Updated
December 1, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share